Talphera, Inc. (NASDAQ:TLPH – Get Free Report)’s stock price rose 1.7% during trading on Tuesday . The stock traded as high as $1.02 and last traded at $0.95. Approximately 20,477 shares traded hands during trading, a decline of 83% from the average daily volume of 119,366 shares. The stock had previously closed at $0.93.
Wall Street Analyst Weigh In
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $6.00 target price on shares of Talphera in a report on Thursday, March 7th.
Read Our Latest Research Report on TLPH
Talphera Trading Up 1.7 %
Talphera (NASDAQ:TLPH – Get Free Report) last issued its earnings results on Wednesday, March 6th. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by ($0.01). The firm had revenue of $0.28 million for the quarter. As a group, equities analysts predict that Talphera, Inc. will post -1.12 EPS for the current year.
Talphera Company Profile
Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.
Recommended Stories
- Five stocks we like better than Talphera
- Canadian Penny Stocks: Can They Make You Rich?
- Charles Schwab Fortifies its Uptrend on EPS Beat
- How to Capture the Benefits of Dividend Increases
- Lockheed Martin Stock Aims for a Fresh All-Time High
- 3 Monster Growth Stocks to Buy Now
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Talphera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talphera and related companies with MarketBeat.com's FREE daily email newsletter.